Patent · US Active

Transcutaneous neuromodulation system and methods of using same

US11638820B2 · kind B2 · utility

2Cited by
116References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 4, 2021
Grant dateMay 2, 2023
Priority date
Expiry dateMar 27, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N1/36171
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A neuromodulation system and a method of inducing voluntary movement in a mammal with a spinal injury are disclosed. In an example, a neuromodulation system includes a processor, a signal generator, and at least one electrode. The processor, in cooperation with the signal generator and the at least one electrode are configured to deliver a transcutaneous stimulation to a mammal. The transcutaneous stimulation includes during a first time period, a transcutaneous electrical spinal cord stimulation (“tESCS”) applied to the mammal during physical conditioning of the mammal. The transcutaneous stimulation also includes during a second time period after the first time period, the tESCS applied to the mammal during reduced or no physical conditioning of the mammal. The tESCS applied during the first time period and the second time period is used to establish a functional baseline of the mammal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.